Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB957 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human GDF-15 Monoclonal Antibody (Clone 147627)
- Antibody type
- Monoclonal
- Antigen
- Chinese hamster ovary cell line CHO-derived recombinant human GDF-15, Ala197-Ile308
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
Q99988.2
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references TGF-β contamination of purified recombinant GDF15.
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy.
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Olsen OE, Skjærvik A, Størdal BF, Sundan A, Holien T
PloS one 2017;12(11):e0187349
PloS one 2017;12(11):e0187349
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.
Maetzler W, Deleersnijder W, Hanssens V, Bernard A, Brockmann K, Marquetand J, Wurster I, Rattay TW, Roncoroni L, Schaeffer E, Lerche S, Apel A, Deuschle C, Berg D
PloS one 2016;11(3):e0149349
PloS one 2016;11(3):e0149349
Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Li J, Veltri RW, Yuan Z, Christudass CS, Mandecki W
PloS one 2015;10(4):e0122249
PloS one 2015;10(4):e0122249
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.
Tanno T, Lim Y, Wang Q, Chesi M, Bergsagel PL, Matthews G, Johnstone RW, Ghosh N, Borrello I, Huff CA, Matsui W
Blood 2014 Jan 30;123(5):725-33
Blood 2014 Jan 30;123(5):725-33
Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy.
Foley PW, Stegemann B, Ng K, Ramachandran S, Proudler A, Frenneaux MP, Ng LL, Leyva F
European heart journal 2009 Nov;30(22):2749-57
European heart journal 2009 Nov;30(22):2749-57
Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL
European heart journal 2009 May;30(9):1057-65
European heart journal 2009 May;30(9):1057-65
No comments: Submit comment
No validations: Submit validation data